An amendment, printed as amendment No. 12 in the Congressional Record of July 9, 1996 to prohibit the use of funds appropriated in the bill to be used by the Secretary of Health and Human Services to enter into an agreement to grant a private company exlusive rights to market drugs developed by the National Institutes of Health, unless the sale of the the drug is subject to a reasonable price agreement, or such an agreement is determined to be not required.

failedUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

On agreeing to the Sanders amendment (A024) Failed by recorded vote: 180 - 242 (Roll no. 306).

Records

Official amendment HAMDT 1273 (104th) from United States at United States Congress. Status: On agreeing to the Sanders amendment (A024) Failed by recorded vote: 180 - 242 (Roll no. 306)..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1997

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/104th-congress/hamdt-1273
Open data entity: https://api.congress.gov/v3/amendment/104/hamdt/1273
us · 104-hamdt-1273 · source updated 15 August 2021